This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
We salute industry experts helping companies survive and sustain in this economic pandemic; they are working day and night to help companies take rapid-decisions by finding
# Covid Impact on Proteomics Market, growth/decline in product type/use cases of Proteomics Market due to cascaded impact of Covid on Extended Ecosystem..
# How top 50 companies in Proteomics Market are making rapid shifts in their strategies as we speak here...
# Outside-in view of top 50 companies client and client’s clients shifting short-term priorities
Let’s fight this crisis together.
Download PDF Brochure@
By instrumentation technology, the spectroscopy segment is expected to account for the largest share of the proteomics market
The proteomics market, by instrumentation technology, is segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, and protein fractionation. The spectroscopy segment accounted for the largest market share in 2018. The ability of spectroscopy to quantify the complex structure of proteins on a large scale and its capability to integrate with other technologies for protein quantification make spectroscopy an indispensable tool in proteomics. This contributes to the large share of the segment.
The use of immunoassay reagents is increasing with the rising need for precise protein identification
Based on reagent, the proteomics market is segmented into protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, and protein fractionation reagents. The immunoassay reagents segment is estimated to account for the largest market share in 2018, mainly due to the ability to quickly and easily provide precise and accurate results for protein identification and separation, which form the initial steps for proteome analysis.
Recent Developments
# In October 2018, Waters Corporation launched its RenataDX Screening System
# In October 2018, Thermo Fisher Scientific, Inc. (US) collaborated with Symphogen (Denmark) under which Symphogen will use the Thermo Scientific Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry (LC/MS/MS) system with its BioPharma Option to create, test, and validate platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures.
# In July 2018, Thermo Fisher Scientific, Inc. (US) launched the Quadrupole-Orbitrap Mass Spectrometer
# In May 2018, Agilent acquired Advanced Analytical Technologies, Inc. (US). This acquisition enhanced Agilent’s technology base to provide customers with a comprehensive set of solutions for next-generation sequencing workflows.
# In May 2018, PerkinElmer acquired Shanghai Spectrum Instruments Co., Ltd. (SSI) (China), one of the leading manufacturers of analytical instruments in China. This will help the firm in building its footprint in China through SSI’s localized leading market position.
Request Sample Pages@
North America to dominate the proteomics market during the forecast period
In 2018, North America dominated the global proteomics market, followed by Europe. Increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, rising demand for high-quality research tools for data reproducibility, and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes are the factors propelling the growth of the market in the region.
Prominent players in the proteomics market are Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc.(US), GE Healthcare (US), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Luminex Corporation (US), Bruker Corporation (US), Merck KGaA,(Germany), Waters Corporation (US), PerkinElmer, Inc. (US), Creative Proteomics (US), and Promega Corporation (US).
Critical questions the report answers:
# Where will all these developments take the industry in the long term?
# What are the upcoming trends in the proteomics market?
# Which segment provides the most opportunity for growth?
# Who are the leading vendors operating in this market?
# What are the opportunities for new market entrants?
No comments:
Post a Comment